Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
Clinical trial NCT00722176 · COMPLETED
Trial details
- NCT number
- NCT00722176
- Sponsor
- BioLineRx, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-07-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.